Correlation between Doppler vascular density and PSA response to radiation therapy in patients with localized prostate carcinoma

Academic Radiology

Volumn 10, Issue 4, 2003, Pages 366-372

  Sehgal, Chandra M ^a   Arger, Peter H ^a   Holzer, Anson C ^a   Krisch, Robert E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Prostate neoplasms, therapeutic radiology; Prostate neoplasms, US

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DENSITY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; HALF LIFE TIME; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CARCINOMA; TREATMENT PLANNING; ULTRASOUND;

EID: 0037382417     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)80024-7     Document Type: Article

References (26)

1. Kelly IM, Lees WR, Rickards D. Prostate cancer and the role of color Doppler US. Radiology 1993; 189:153-156.
2. Newman JS, Bree RL, Rubin JM. Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 1995; 195:86-90.
3. Patel U, Rickards D. Diagnostic value of colour Doppler flow in the peripheral zone of the prostate, with histological correlation. Br J Urol 1994; 74:590-595.
4. El-Gabry EA, Halpern EJ, Strup SE, Gomella LG. Imaging prostate cancer: current and future applications. Oncology 2001; 15:325-336.
5. Potdevin TC, Moskalik, Fowlkes JB, Bude RO, Carson PL. Doppler quantitative measures by region to discriminate prostate cancer. Ultrasound Med Biol 2001; 27:1305-1310.
6. Halpern EJ, Rosenberg M, Gomella LG. Prostate cancer: contrast-enhanced US for detection. Radiology 2001; 219:219-225.
7. Bree RL. The role of color Doppler and staging biopsies in prostate cancer detection. Urology 1997; 49:31-34.
8. Halpern EJ, Frauscher F, Forsberg F, et al. High frequency Doppler US of the prostate: effects of patient position. Radiology 2002; 222:634-639.
9. Evans SM, Laughlin KM, Pugh CR, Sehgal CM, Saunders HM. Use of power Doppler ultrasound to locate regions of tumor hypoxia. Br J Cancer 1997; 76:1308-1314.
10. Sehgal CM, Arger PH, Pugh CR, Kirchofer JI, Kotlar EY, Bovee KC. Comparison of power Doppler and B-scan for renal imaging using a sonographic contrast agent. J Ultrasound Med 1998; 17:751-756.
11. Arger PH, Sehgal CM, Pugh CR, Kotlar EY, Kirchofer JI, Bovee KC. Evaluation of change in blood flow by contrast-enhanced power Doppler imaging during norepinephrine-induced renal vasoconstriction. J Ultrasound Med 1999; 18:843-851.
12. Sehgal CM, Arger PH, Rowling SE, Conant EF, Reynolds C, Patton JA. Quantitative vascularity of breast masses by Doppler imaging: regional variations and diagnostic implications. J Ultrasound Med 2000; 19:427-440.
13. Gee MS, Saunders HM, Lee JC, et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res 2001; 61:2974-2982.
14. Sehgal CM, Arger PH, Silver AC, et al. Renal blood flow changes induced with endothelin-1 and fenoldopam mesylate using quantitative Doppler US: initial results in a canine study. Radiology 2001; 219:419-426.
15. Hall MC, Tronscoso P, Pollack A, et al. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 1994; 44:869-875.
16. Cosgrove DO, Kedar RP, Bamber JC, et al. Breast diseases: color Doppler US in differential diagnosis. Radiology 1993; 189:99-104.
17. Huber S, Delorme S, Knopp MP, et al. Breast tumors: computer-assisted quantitative assessment with color Doppler US. Radiology 1994; 192:797-801.
18. Meyerowitz CB, Fleisher AC, Pickens DR, et al. Quantification of tumor vascularity and flow with amplitude color Doppler sonography in an experimental model: preliminary results. J Ultrasound Med 1996; 15: 827-833.
19. Carson PL, Fowlkes JB, Roubidoux MA, et al. 3D color Doppler image quantification of breast masses. Ultrasound Med Biol 1998; 24:945-952.
20. Ismail M, Petersen RO, Alexander AA, Craig N, Gomella LG. Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology 1997; 50:906-912.
21. Strohmeyer D, Frauscher F, Klauser A, et al. Contrast-enhanced transrectal color Doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. Anticancer Res 2001; 21:2907-2914.
22. Sedelaar JPM, van Leenders GJLH, Hulsbergen-van de Kaa CA, et al. Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol 2001; 40:285-293.
23. Humphery PA, Vollmer RT. Relationships between serum prostate-specific antigen and histopathologic appearance of prostate carcinoma. In: Foster CS, Bostwick DG, eds. Pathology of the prostate. Major Problems in Pathology, vol 34. Philadelphia, Pa: Saunders, 1998; 14:253-281.
24. Zagars GK, Pollack A. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol 1997; 44:213-221.
25. Stamey TA, Yang N, Hay AR, McNeal JE, Freisha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 15:909-916.
26. Hall EJ. Radiobiology for the radiologist. 4th ed. Philadelphia, Pa: Lippincott, 1994; 211-229.